Drug Type Small molecule drug |
Synonyms NWL-149 |
Target |
Mechanism CASP4 modulators(caspase 4 modulators), caspase 1 modulators(ICE modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Degenerative disorder | Preclinical | CA | 30 Jan 2022 | |
Multiple Sclerosis | Preclinical | CA | 30 Jan 2022 | |
Alzheimer Disease | Preclinical | CA | - | |
Heart Diseases | Preclinical | CA | - | |
Inflammation | Preclinical | CA | - |